Machine learning approaches to optimize small-molecule inhibitors for RNA targeting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2946
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Machine learning approaches to optimize small-molecule inhibitors for RNA targeting ; volume:14 ; number:1 ; day:2 ; month:2 ; year:2022 ; pages:1-15 ; date:12.2022
Journal of cheminformatics ; 14, Heft 1 (2.2.2022), 1-15, 12.2022
- Creator
-
Grimberg, Hadar
Tiwari, Vinay S.
Tam, Benjamin
Gur-Arie, Lihi
Gingold, Daniela
Polachek, Lea
Akabayov, Barak
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13321-022-00583-x
- URN
-
urn:nbn:de:101:1-2022051121425403053407
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grimberg, Hadar
- Tiwari, Vinay S.
- Tam, Benjamin
- Gur-Arie, Lihi
- Gingold, Daniela
- Polachek, Lea
- Akabayov, Barak
- SpringerLink (Online service)
Other Objects (12)
6 Small-Molecule Motion
Development of novel small-molecule inhibitors targeting the HGF/MET pathway
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Small-molecule modifiers for DNA nanostructures
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
6 Small-Molecule Motion
Development of novel small-molecule inhibitors targeting the HGF/MET pathway
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Small-molecule modifiers for DNA nanostructures
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
6 Small-Molecule Motion
Development of novel small-molecule inhibitors targeting the HGF/MET pathway
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Small-molecule modifiers for DNA nanostructures